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Recently, uterine cervical cancer in the young generation has been
increasing in Japan. Since Japanese females have tended to marry
later in life during the past several decades, it is not rare that cervical
cancer patients require radical trachelectomy (RT) to retain fertility.
Since D'Argent et al. performed the ﬁrst vaginal radical trachelectomy
(VRT) in 1987, this procedure has become widespread throughout
the world. Due to the narrow vaginal anatomy of Japanese women,
abdominal radical trachelectomy (ART) has been performed in most
cases (74.7%, 201/269) in Japan (Sato et al., 2011). RT has been
adapted for patients with stage Ia1-Ib1 cancer, and neoadjuvant che-
motherapy followed by VRT has been attempted for larger tumors
(Marchiole et al., 2011; Gottschalk et al., 2011).
In this report, a patient with stage Ib2 squamous carcinoma was
treated with neoadjuvant intra-arterial chemotherapy followed by
ART. Subsequently, she successfully became pregnant and gave birth.
Case
The patient was a 22-year-old Japanese woman, who was single
and nulligravida. Her chief complaint was abnormal genital bleeding.
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Open access under CC BY-NC-ND license.vaginal discharge since February 200X, and the amount of genital
bleeding had gradually increased. Pap smear revealed class V squa-
mous cell carcinoma (SCC), and a biopsy exam revealed moderate
dysplasia. Thus, she was subsequently transferred to a local hospital
in March 200X. A cervical tumor with exophytic growth was detected,
and the biopsy specimen revealed a potential verrucous carcinoma.
Therefore, an abdominal radical hysterectomy was recommended.
However, due to her young age, fertility preservation was desired,
and she was recommended to our hospital.
A papillary growth cervical carcinoma measuring over 4 cm in
diameter was detected upon inspection. A pelvic exam revealed that
the uterus was normal in size, the bilateral adnexae were not palpable,
and the bilateral parametriumwas soft. A second Pap smear performed
by us showed a class V SCC tumor with broad necrotic tissue and
large atypical cells. Further, another biopsy revealed squamous cell car-
cinoma with typical warty appearance and intercellular bridges
consisting of less atypical cells with broad cytoplasm. Thus, this tumor
was diagnosed as verrucous carcinoma.
Analyses for tumor markers showed the following: CEA 0.8 ng/ml,
CA19-9 17.2 U/ml, CA125 12 U/ml, CYFRA 1.1 ng/ml, NSE 6.7 ng/ml,
and SCC 4.6 ng/ml. Human papillomavirus (HPV) type 31 was also
detected.
A pelvic MRI showed the presence of a uterine cervical tumor with
exophytic growth (Fig. 1).
Although this case was a stage Ib2 bulky cervical carcinoma, tumor
histology was well-differentiated and stromal invasion seemed shal-
low. Based on this diagnosis, intra-arterial neoadjuvant chemothera-
py (IANAC) was performed followed by surgery. The chemotherapy
regimen included cisplatin (CDDP) 100 mg/body and mitomycin C
(MMC) 10 mg/body administered by insertion of the catheter into
the right femoral artery and placement of the catheter tip into the bi-
lateral internal iliac artery. Bolus infusions at half dose were given to
the left and right internal iliac arteries (Park et al., 1995).
IANAC was initially administered on March 22, 200X. Two weeks
later, an obvious shrinkage of the tumor was observed. Tumor diam-
eter had decreased to approximately 2 cm. A second course of IANAC
was administered on April 12, 200X, and two weeks later, the tumor
could no longer be observed by the naked eye (Fig. 2). An MRI
performed on April 27, 200X showed that the residual tumor mea-
sured 12×9×6 mm in size. No severe adverse effects of IANAC
were observed. The level of SCC Ag declined from 4.6 ng/ml to
0.9 ng/ml.
Fertility-sparing surgery was considered, and ART was performed
on May 2, 200X. Bilateral uterine arteries and pelvic nerve were
Fig. 1. A pelvic MRI showing the presence of a uterine cervical tumor with exophytic growth, measuring 46×42×12 mm, that was mainly located on the anterior cervical lip, but
tumor invasion seemed shallow (a), and parametrium invasion and pelvic lymphadenopathy were not detected (b).
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upon dissection, and a negative endocervical cut end was shown by
frozen histological diagnosis. ART was successfully completed, and a
cervical cerclage with polydioxanone (PDS) suture was placed. Oper-
ation time was 5 h and 21 min, and blood loss was 436 ml.
The excised specimen included only a tiny papillary tumor. The
ﬁnal pathological diagnosis was a microinvasive well-differentiated
squamous cell carcinoma with no pelvic lymph node metastasis.
No adjuvant treatment was needed, and she was placed under our
observation.
This patient married on May, 200X+1. After marriage, she tried
to conceive, but she experienced difﬁculties. Beginning on May,
200X+2, artiﬁcial insemination by the husband was performed 5
times, but she failed to get pregnant. Then, on May, 200X+4, she
received in vitro fertilization and embryo transfer (IVF–ET), and she
ﬁnally conceived.
After conception, she was admitted to our hospital at 10 weeks
of gestation for bed rest. Cervical cerclage with nylon suture was
performed at 12 weeks and 2 days of gestation. From around
16 weeks of gestation, a small amount of genital bleeding began;
thus, absolute bed rest was instructed. The fetus was in the vertex
presentation, and rupture of the membrane occurred at 27 weeks
and 6 days. Thus, an emergency Cesarean section was performed at
28 weeks of gestation. The immature male baby was born, weighing
1258 g, and had Apgar scores of 5 at 1 min and 6 at 5 min. The
post-operative course was mostly uneventful. Five years and fourFig. 2. A papillary growth cervical carcinoma, measuring over 4 cm in diameter, was detec
naked eye (b).months after the trachelectomy, she has been alive without disease
and her child has been growing favorably.
Discussion
This is the world's ﬁrst case of a patient treated with neoadjuvant
chemotherapy for bulky cervical cancer of stage Ib2 followed by ART,
who subsequently conceived and gave birth successfully.
VRT is limited by the resectable size of the parametrium from the
uterine cervix because of the narrowness of the vagina (Einstein et al.,
2009). However, for the cases with large tumors (2–4 cm), several
reports describing the use of VRT after neoadjuvant chemotherapy
(NAC) have emerged in recent years (Marchiole et al., 2011; Gottschalk
et al., 2011). Tsubamoto et al. (2012) reported a case series, where 3 pa-
tients with stage Ib bulky cervical carcinoma underwent simple vaginal
trachelectomy and abdominal lymphadenectomy with resection of
paracervical tissues after NAC. However, no pregnancies were sought
among them.
Recently, Abu-Rustum et al. (2008) performed ART for cancer pa-
tients with stage Ib1. Although themajority of their patients underwent
successful surgery, nearly 32% required hysterectomy or postoperative
chemoradiation for oncologic reasons. Thus, about one third of the
stage Ib1 patients treated by ART had risk factors that required adjuvant
therapy after surgery.
Nishio et al. (2009) performed ART for 61 patients. There were
six recurrences (9.8%), none of which occurred in patients with tumorsted (a). After a second course of IANAC, the tumor could no longer be observed by the
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ommended for patients with a tumor diameter of b2 cm. In Japan,
nerve sparing radical hysterectomy has been widely utilized since the
radicality of this procedure seems to be less than the conventional
one. However, Nishio et al. did not include details about its indications
and extent of the nerve sparing procedure. If preoperative imaging is
able to accurately conﬁrm shallow stromal invasion and no lymph
node metastasis, and excessive nerve sparing is not utilized, then ART
can be performed more safely with higher curative rates.
In 2011, Lukas et al. (2011) reviewed the performance of ART in
Ib1 tumors larger than 2 cm. There was a higher risk of extrauterine
spread and the risk of recurrence was signiﬁcantly higher. However,
their review mainly discussed results from 3 papers, one of which
was by Nishio et al in 2009 as mentioned above while the other two
are relatively old and thus may not be applicable to the current situ-
ation. In contrast, Li et al. (2011) performed ART for 62 patients, 14 of
36 Ib1 cases had tumors >2 cm, and no recurrences were observed at
a median follow-up of 22.8 months.
Cancer treatment with fertility preservation is an important alter-
native option especially among younger patients with small tumors.
But regardless of the tumor size, radical trachelectomy should be
performed only when the patient adequately understands the many
pregnancy-related risks after surgery, for example premature birth,
and truly desires it.
In this report, a patient with bulky cervical cancer stage Ib2 was
diagnosed carefully with regard to histology, depth of invasion and
tumor spread. NAC was administered, thereby fertility preservation
and radicality were sustained. After a 5-year follow-up period, there
is no evidence of disease, and the child has shown no adverse effects
of treatment. This case is the ﬁrst case of successful pregnancy and
delivery after NAC and abdominal radical trachelectomy. This report
may bear great signiﬁcance and provide useful information towardstreatment of young cervical cancer patients especially with respect
to fertility preservation.
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